Feed FSPKF
FS

Fisher & Paykel Healthcare Corporation Limited

FSPKF · OTC

$25.79 +0.00% (+$0.00)
1M +5.05%
Market Cap $26.1B
P/E Ratio 55.13x
Div. Yield 1.53%
ROE 23.88%

Bulios Fair Price

$17.22

33.2% downside

Current Price

$25.79

Undervalued Fair Value Overvalued

According to Bulios Fair Price, FSPKF is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
8/9
Valuation
5 /100
Expensive
P/E 55.13x
EV/EBITDA 30.90x
PEG 2.17x
Growth
91 /100
Growing
EPS growth 23.50%
Rev. growth 14.14%
Book val. growth 6.81%
Profitability
100 /100
Strong
Gross margin 64.16%
Net margin 20.03%
FCF margin 20.97%
Quality
95 /100
Excellent
ROIC 20.72%
ROE 23.88%
Asset turnover 0.82x
Debt
100 /100
Low
Debt/Equity 0.07x
Current ratio 2.31x
Net debt/EBITDA -0.38x
Stability
40 /100
Moderate
Beta 0.89x
Rev. volatility 56.81%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about FSPKF
Online

About the company

Fisher & Paykel Healthcare Corporation is a New Zealand-based company specializing in the development and manufacture of innovative healthcare devices. Founded in 1934, its products include systems for respiratory support, ventilation, anesthesia, and homecare tools. The company is known for its advanced technologies that improve patient care and are used globally.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Lewis G. Gradon

Employees

7,661

Headquarters

Auckland

Upcoming events

24 NOV

Earnings

Upcoming earnings report

72d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.